CD8A and familial dilated cardiomyopathy: Although direct evidence regarding the role of CD8+ T-cell depletion in DCM is limited, given the core role of cardiac fibrosis in DCM progression, inhibition of CD8+ T-cell activation may be a promising therapeutic strategy to restrict cardiac fibrosis during DCM and protect against DCM progression.